Continuous axial-flow left ventricular assist device (Jarvik 2000) maintains kidney and liver perfusion for up to 6 months
- 1 October 2003
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 76 (4) , 1167-1170
- https://doi.org/10.1016/s0003-4975(03)00724-0
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Initial Clinical Experience With the Jarvik 2000 Implantable Axial-Flow Left Ventricular Assist SystemCirculation, 2002
- Implant technique for the Jarvik 2000 heartThe Annals of Thoracic Surgery, 2002
- Hepatic dysfunction after left ventricular mechanical assist in patients with end-stage heart failure: role of inflammatory response and hepatic microcirculationThe Annals of Thoracic Surgery, 2002
- Research and development of an implantable, axial-flow left ventricular assist device: the Jarvik 2000 HeartThe Annals of Thoracic Surgery, 2001
- Improved outcomes with an implantable left ventricular assist system: a multicenter studyThe Annals of Thoracic Surgery, 2001
- One hundred patients with the HeartMate left ventricular assist device: evolving concepts and technologyThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Evolution of battery-powered, vented left ventricular assist devicesThe Annals of Thoracic Surgery, 1996
- Hemodynamic and physiologic changes during support with an implantable left ventricular assist deviceThe Journal of Thoracic and Cardiovascular Surgery, 1995